China Daily
First bivalent mRNA vaccine candidate against RSV goes under clinical trial
The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical trial in China on Wednesday, as an adult received a shot at a clinical ...
2 日前